Skip to content
2000
Volume 2, Issue 6
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Morphiceptin (Tyr-Pro-Phe-Pro-NH2) is one of the most selective agonists for the μ-opioid receptor. In this review structure-activity relationships of morphiceptin analogues and studies resulting in defining low energy conformations are discussed. Finally, new developments in the control of tumour growth and cell proliferation by morphiceptin analogues are surveyed, which open future perspectives in the diagnosis and treatment of various cancers.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/1389557023405567
2002-12-01
2025-09-02
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/1389557023405567
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test